<DOC>
	<DOCNO>NCT02176252</DOCNO>
	<brief_summary>The study design evaluate safety , tolerability , pharmacodynamics pharmacokinetics AZD1722 healthy Japanese subject increase dos give 7 day order allow include Japanese subject future global study . A cohort Caucasian subject include study evaluate cardiac effect , assess digital ECGs ( dECG ) recording , also Caucasian subject .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamic AZD1722 Healthy Male Female Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy man woman Body mass index 18 29.9 kg/m2 , inclusive Diagnosis treatment clinically symptomatic biochemical structural abnormality gastrointestinal ( GI ) tract Any surgery small intestine colon , exclude appendectomy Clinical evidence significant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematologic , metabolic , endocrine , neurologic , psychiatric disease , condition may interfere subject successfully complete trial would present safety risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>